Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    (2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 89Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Labeler NDC Package Code Non Proprietary Name Start Marketing Date End Marketing Date Category Code Dosage Form (Strength)
    29/11/2025 Kyowa Hakko Bio
    Japan
    		 KYOWA HAKKO BIO CO., LTD. 12497-1032 L-Histidine 1978-03-15 2025-12-31 BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING POWDER (50kg/50kg)
    29/11/2025 Pcca
    United Kingdom
    		 Professional Compounding Centers of America 51927-0308 Histidine 2023-08-03 2025-12-31 BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING POWDER (1kg/kg)